TRAEs reported in a single participant in ≥ 1 treatment arm were abdominal distension, alopecia, constipation, decreased appetite, dry skin, dyspepsia, fatigue, increased ALT, insomnia, lower abdominal pain, musculoskeletal pain, musculoskeletal stiffness, myalgia, nausea, night sweats, pain in extremity, pollakiuria, and upper abdominal pain. This evidence concerns the gene GPT and dyspepsia.